Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Plos One|June 5, 2012
Comparison of recombinant human haptocorrin expressed in human embryonic kidney cells and native haptocorrinEvelyne Furger, Sergey N Fedosov, Dorte Launholt Lildballe, et al.
Bioconjugate Chemistry|February 4, 2014
Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugatesPatrick Dennler, Aristeidis Chiotellis, Eliane Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2014
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer modelJürgen Grünberg, Dennis Lindenblatt, Holger Dorrer, et al.
The Journal of Biological Chemistry|June 8, 2014
Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activityRoberta Bianchi, Eliane Fischer, Don Yuen, et al.
The International Journal of Biochemistry & Cell Biology|April 30, 2009
The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factorAlexandra Friedli, Eliane Fischer, Ilse Novak-Hofer, et al.
Molecular Pharmaceutics|February 22, 2017
Radiolabeled 111In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo ImagingAlessandra Moscaroli, Gabriel Jones, Tessa Lühmann, et al.
International Journal of Cancer|July 29, 2011
L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancerEliane Fischer, Jürgen Grünberg, Susan Cohrs, et al.
Nuclear Medicine and Biology|August 17, 2011
The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapySilvia Lehenberger, Christoph Barkhausen, Susan Cohrs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2012
Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodiesEliane Fischer, Krishna Chaitanya, Thomas Wüest, et al.
Anticancer Research|April 16, 2010
Yeast-based identification of prostate tumor antigens provides an effective vaccine platformVolker Jung, Eliane Fischer, Jochen Imig, et al.
Pageof 4